ArticleHepatology international2023

Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?

Renguo Guan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.